What is insmed incorporated insm? Insmed Incorporated (Nasdaq:INSM), a global biopharmaceutical company on a mission to transform the lives of patients with serious and rare diseases, today reported financial results for the second quarter ended June 30, 2021 and provided a business update.What does insmed incorporated do for the rare disease community? As a champion for the rare disease community, we are dedicated to supporting patients and their families along their journey. Insmed Incorporated (Nasdaq: INSM), a global biopharmaceutical company on a mission to transform the lives of patients with serious and rare diseases, today announced the granting of inducement...What is it like to work at insmed? Insmed employees work with a profound sense of urgency to deliver technologies and medicines in therapeutic areas with the greatest potential to make a difference in patients’ lives. At Insmed, the needs of patients serve as our compass point when setting priorities for the company and weighing difficult decisions.What happened to insmeds stock? What Happened: A Form 4 filing from the U.S. Securities and Exchange Commission states that John Soriano purchased 17,349 Insmed shares at a price of $13.91 per share for a total of $241,325 on September 7. They then sold their shares on the same day in the open market. They sold at a price of $28.20 to raise a total of $489,242 from the stock